← Open Payments lookup

MELISSA LOWMAN: Open Payments

NPI 1235837279 · RUSSELLVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$391 in 20 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $391

Food & beverage: $391
CompanyPaymentsAmount
Travere Therapeutics, Inc.3$82
Novartis Pharmaceuticals Corporation4$81
Amgen Inc.4$81
SCPHARMACEUTICALS INC.3$47
Bayer Healthcare Pharmaceuticals Inc.2$31
Vifor Pharma, Inc.1$24
AstraZeneca Pharmaceuticals LP1$17
Boehringer Ingelheim Pharmaceuticals, Inc.1$15
AKEBIA THERAPEUTICS INC1$15

Products named: KRYSTEXXA, FUROSCIX, Kerendia, Veltassa, FARXIGA, JARDIANCE, Vafseo.

Industry payments across AR — which companies pay providers there.